Other Species / Isoforms
  NMDAR2A (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
N75
NVVALLMNRTDPKSL
0 1
NMDAR2A (human) NVVALLMNRTDPKSL N75
NMDAR2A (mouse) NVVALLMnRTDPKSL N75-ng
NMDAR2A (rat) NVVALLMNRTDPKSL N75
T104
GLVFGDDTDQEAVAQ
0 1
NMDAR2A (human) GLVFGDDtDQEAVAQ T104-p
NMDAR2A (mouse) GLVFGDDTDQEAVAQ T104
NMDAR2A (rat) GLVFGDDTDQEAVAQ T104
T120
LDFISSQTFIPILGI
0 1
NMDAR2A (human) LDFISSHtFVPILGI T120-p
NMDAR2A (mouse) LDFISSQTFIPILGI T120
NMDAR2A (rat) LDFISSQTFIPILGI T120
S274
LIPKEFPSGLISVSY
0 1
NMDAR2A (human) LIPKEFPsGLIsVsy S274-p
NMDAR2A (mouse) LIPKEFPSGLISVSY S274
NMDAR2A (rat) LIPKEFPSGLISVSY S274
S278
EFPSGLISVSYDDWD
0 1
NMDAR2A (human) EFPsGLIsVsyDDWD S278-p
NMDAR2A (mouse) EFPSGLISVSYDDWD S278
NMDAR2A (rat) EFPSGLISVSYDDWD S278
S280
PSGLISVSYDDWDYS
0 1
NMDAR2A (human) PsGLIsVsyDDWDYS S280-p
NMDAR2A (mouse) PSGLISVSYDDWDYS S280
NMDAR2A (rat) PSGLISVSYDDWDYS S280
Y281
SGLISVSYDDWDYSL
0 1
NMDAR2A (human) sGLIsVsyDDWDYSL Y281-p
NMDAR2A (mouse) SGLISVSYDDWDYSL Y281
NMDAR2A (rat) SGLISVSYDDWDYSL Y281
N380
EKVGKWENQTLSLRH
0 1
NMDAR2A (human) EKVGKWENHTLSLRH N380
NMDAR2A (mouse) EKVGKWEnQTLSLRH N380-ng
NMDAR2A (rat) EKVGKWENQTLSLRH N380
Y393
RHAVWPRYKSFSDCE
0 1
NMDAR2A (human) RHAVWPRyKSFSDCE Y393-p
NMDAR2A (mouse) RHAVWPRYKSFSDCE Y393
NMDAR2A (rat) RHAVWPRYKSFSDCE Y393
K438
RNTVPCRKFVKINNS
0 1
NMDAR2A (human) RNTVPCRKFVKINNS K438
NMDAR2A (mouse) RNTVPCRkFVKINnS K438-ac
NMDAR2A (rat) RNTVPCRKFVKINNS K438
N444
RKFVKINNSTNEGMN
0 1
NMDAR2A (human) RKFVKINNSTNEGMN N444
NMDAR2A (mouse) RkFVKINnSTNEGMN N444-ng
NMDAR2A (rat) RKFVKINNSTNEGMN N444
K453
TNEGMNVKKCCKGFC
0 1
NMDAR2A (human) TNEGMNVKKCCKGFC K453
NMDAR2A (mouse) TNEGMNVkKCCKGFC K453-ac
NMDAR2A (rat) TNEGMNVKKCCKGFC K453
T470
ILKKLSRTVKFTYDL
0 1
NMDAR2A (human) ILKKLSRtVKFTYDL T470-p
NMDAR2A (mouse) ILKKLSRTVKFTYDL T470
NMDAR2A (rat) ILKKLSRTVKFTYDL T470
Y502
GMIGEVVYQRAVMAV
0 1
NMDAR2A (human) GMIGEVVYQRAVMAV Y502
NMDAR2A (mouse) GMIGEVVyQRAVMAV Y502-p
NMDAR2A (rat) GMIGEVVYQRAVMAV Y502
S511-p
RAVMAVGsLTINEER
1 1
NMDAR2A (human) RAVMAVGSLTINEER S511
NMDAR2A (mouse) RAVMAVGSLTINEER S511
NMDAR2A (rat) RAVMAVGsLTINEER S511-p
S580-p
VFVFEYFsPVGYNRN
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • CDK1 (rat)
Putative in vivo kinases:
  • CDK1 (rat)
NMDAR2A (human) VFVFEYFSPVGYNRN S580
NMDAR2A (mouse) VFVFEYFSPVGYNRN S580
NMDAR2A (rat) VFVFEYFsPVGYNRN S580-p
S719
GVEDALVSLKTGKLD
0 1
NMDAR2A (human) GVEDALVsLKTGKLD S719-p
NMDAR2A (mouse) GVEDALVSLKTGKLD S719
NMDAR2A (rat) GVEDALVSLKTGKLD S719
Y730
GKLDAFIYDAAVLNY
0 2
NMDAR2A (human) GKLDAFIyDAAVLNy Y730-p
NMDAR2A (mouse) GKLDAFIYDAAVLNY Y730
NMDAR2A (rat) GKLDAFIYDAAVLNY Y730
Y737
YDAAVLNYKAGRDEG
0 1
NMDAR2A (human) yDAAVLNyKAGRDEG Y737-p
NMDAR2A (mouse) YDAAVLNYKAGRDEG Y737
NMDAR2A (rat) YDAAVLNYKAGRDEG Y737
T749
DEGCKLVTIGSGYIF
0 1
NMDAR2A (human) DEGCKLVtIGSGYIF T749-p
NMDAR2A (mouse) DEGCKLVTIGSGYIF T749
NMDAR2A (rat) DEGCKLVTIGSGYIF T749
K880
GVHIEEKKKsPDFNL
0 1
NMDAR2A (human) GVHIEEKkKSPDFNL K880-m1
NMDAR2A (mouse) GVHIEEKKKsPDFNL K880
NMDAR2A (rat) GVHIEEKKKsPDFNL K880
S882-p
HIEEKKKsPDFNLTG
0 6
NMDAR2A (human) HIEEKkKSPDFNLTG S882
NMDAR2A (mouse) HIEEKKKsPDFNLtG S882-p
NMDAR2A (rat) HIEEKKKsPDFNLTG S882-p
T888
KsPDFNLTGsQSNML
0 4
NMDAR2A (human) KSPDFNLTGSQSNML T888
NMDAR2A (mouse) KsPDFNLtGsQsNML T888-p
NMDAR2A (rat) KsPDFNLTGsQSNML T888
S890-p
PDFNLTGsQSNMLKL
0 5
NMDAR2A (human) PDFNLTGSQSNMLKL S890
NMDAR2A (mouse) PDFNLtGsQsNMLKL S890-p
NMDAR2A (rat) PDFNLTGsQSNMLKL S890-p
S892
FNLTGsQSNMLKLLR
0 2
NMDAR2A (human) FNLTGSQSNMLKLLR S892
NMDAR2A (mouse) FNLtGsQsNMLKLLR S892-p
NMDAR2A (rat) FNLTGsQSNMLKLLR S892
S900
NMLKLLRSAKNISNM
2 0
NMDAR2A (human) NMLKLLRsAKNIssM S900-p
NMDAR2A (mouse) NMLKLLRsAkNISNM S900-p
NMDAR2A (rat) NMLKLLRSAKNISNM S900
K902
LKLLRSAKNISNMSN
0 1
NMDAR2A (human) LKLLRsAKNIssMsN K902
NMDAR2A (mouse) LKLLRsAkNISNMsN K902-ub
NMDAR2A (rat) LKLLRSAKNISNMSN K902
S905
LRSAKNISNMSNMNS
0 1
NMDAR2A (human) LRsAKNIssMsNMNs S905-p
NMDAR2A (mouse) LRsAkNISNMsNMNs S905
NMDAR2A (rat) LRSAKNISNMSNMNS S905
N906
RSAKNISNMSNMNSS
0 4
NMDAR2A (human) RsAKNIssMsNMNss S906-p
NMDAR2A (mouse) RsAkNISNMsNMNss N906
NMDAR2A (rat) RSAKNISNMSNMNSS N906
S908
AKNISNMSNMNSSRM
0 4
NMDAR2A (human) AKNIssMsNMNssRM S908-p
NMDAR2A (mouse) AkNISNMsNMNssRM S908-p
NMDAR2A (rat) AKNISNMSNMNSSRM S908
S912
SNMSNMNSSRMDSPK
0 2
NMDAR2A (human) ssMsNMNssRMDsPK S912-p
NMDAR2A (mouse) SNMsNMNssRMDsPK S912-p
NMDAR2A (rat) SNMSNMNSSRMDSPK S912
S913
NMSNMNSSRMDSPKR
0 2
NMDAR2A (human) sMsNMNssRMDsPKR S913-p
NMDAR2A (mouse) NMsNMNssRMDsPKR S913-p
NMDAR2A (rat) NMSNMNSSRMDSPKR S913
S917
MNSSRMDSPKRATDF
0 4
NMDAR2A (human) MNssRMDsPKRAADF S917-p
NMDAR2A (mouse) MNssRMDsPKRAADF S917-p
NMDAR2A (rat) MNSSRMDSPKRATDF S917
S929-p
TDFIQRGsLIVDMVS
2 9
NMDAR2A (human) ADFIQRGsLIMDMVS S929-p
NMDAR2A (mouse) ADFIQRGsLIVDMVs S929-p
NMDAR2A (rat) TDFIQRGsLIVDMVS S929-p
S936
sLIVDMVSDKGNLIy
0 1
NMDAR2A (human) sLIMDMVSDkGNLMy S936
NMDAR2A (mouse) sLIVDMVsDKGNLIy S936-p
NMDAR2A (rat) sLIVDMVSDKGNLIy S936
K938
IVDMVSDKGNLIysD
0 1
NMDAR2A (human) IMDMVSDkGNLMysD K938-ub
NMDAR2A (mouse) IVDMVsDKGNLIysD K938
NMDAR2A (rat) IVDMVSDKGNLIysD K938
Y943-p
SDKGNLIysDNRsFQ
Upstream
2 136
Treatment
  • ischemia/reperfusion
NMDAR2A (human) SDkGNLMysDNRSFQ Y943-p
NMDAR2A (mouse) sDKGNLIysDNRsFQ Y943-p
NMDAR2A (rat) SDKGNLIysDNRsFQ Y943-p
S944-p
DKGNLIysDNRsFQG
1 5
NMDAR2A (human) DkGNLMysDNRSFQG S944-p
NMDAR2A (mouse) DKGNLIysDNRsFQG S944-p
NMDAR2A (rat) DKGNLIysDNRsFQG S944-p
S948-p
LIysDNRsFQGKDSI
Upstream
1 3
Treatment
  • ischemia/reperfusion
NMDAR2A (human) LMysDNRSFQGKESI S948
NMDAR2A (mouse) LIysDNRsFQGkDSI S948-p
NMDAR2A (rat) LIysDNRsFQGKDSI S948-p
K952
DNRsFQGKDSIFGDN
0 1
NMDAR2A (human) DNRSFQGKESIFGDN K952
NMDAR2A (mouse) DNRsFQGkDSIFGEN K952-ub
NMDAR2A (rat) DNRsFQGKDSIFGDN K952
S976-p
NRHKDNLsNyVFQGQ
1 3
NMDAR2A (human) NRQKDNLNNYVFQGQ N976
NMDAR2A (mouse) NRHKDSLSNYVFQGQ S976
NMDAR2A (rat) NRHKDNLsNyVFQGQ S976-p
Y978-p
HKDNLsNyVFQGQHP
1 2
NMDAR2A (human) QKDNLNNYVFQGQHP Y978
NMDAR2A (mouse) HKDSLSNYVFQGQHP Y978
NMDAR2A (rat) HKDNLsNyVFQGQHP Y978-p
S1025-p
MESLRQDsLNQNPVS
0 8
NMDAR2A (human) VDSIRQDSLSQNPVS S1025
NMDAR2A (mouse) MESLRQDsLNQNPVS S1025-p
NMDAR2A (rat) MESLRQDsLNQNPVS S1025-p
S1048-p
NRTHSLKsPRYLPEE
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, induced
  • receptor internalization, inhibited
Kinase, in vitro:
  • DYRK1A (human)
Putative in vivo kinases:
  • DYRK1A (human)
NMDAR2A (human) NRTHSLKSPRYLPEE S1048
NMDAR2A (mouse) NRTHSLKSPRYLPEE S1048
NMDAR2A (rat) NRTHSLKsPRYLPEE S1048-p
S1059-p
LPEEVAHsDIsETSS
0 5
NMDAR2A (human) LPEEMAHSDISETSN S1059
NMDAR2A (mouse) LPEEVAHsDIsETss S1059-p
NMDAR2A (rat) LPEEVAHsDIsETSS S1059-p
S1062-p
EVAHsDIsETSSRAT
0 5
NMDAR2A (human) EMAHSDISETSNRAT S1062
NMDAR2A (mouse) EVAHsDIsETssRAT S1062-p
NMDAR2A (rat) EVAHsDIsETSSRAT S1062-p
S1065
HsDIsETSSRATCHR
0 1
NMDAR2A (human) HSDISETSNRATCHR S1065
NMDAR2A (mouse) HsDIsETssRATCHR S1065-p
NMDAR2A (rat) HsDIsETSSRATCHR S1065
S1066
sDIsETSSRATCHRE
0 1
NMDAR2A (human) SDISETSNRATCHRE N1066
NMDAR2A (mouse) sDIsETssRATCHRE S1066-p
NMDAR2A (rat) sDIsETSSRATCHRE S1066
S1099-p
SKYPKDCsDVDRtyM
1 4
NMDAR2A (human) SKYPKDCSEVERTyL S1099
NMDAR2A (mouse) SKYPKDCSEVERTyV S1099
NMDAR2A (rat) SKYPKDCsDVDRtyM S1099-p
T1104-p
DCsDVDRtyMKTKAS
1 4
NMDAR2A (human) DCSEVERTyLKTKSS T1104
NMDAR2A (mouse) DCSEVERTyVKTKAS T1104
NMDAR2A (rat) DCsDVDRtyMKTKAS T1104-p
Y1105-p
CsDVDRtyMKTKASS
3 13
NMDAR2A (human) CSEVERTyLKTKSSS Y1105-p
NMDAR2A (mouse) CSEVERTyVKTKASS Y1105-p
NMDAR2A (rat) CsDVDRtyMKTKASS Y1105-p
Y1118-p
SSPRDKIytIDGEKE
2 4
NMDAR2A (human) SSPRDKIyTIDGEKE Y1118-p
NMDAR2A (mouse) SSPRDKIYTIDGEKE Y1118
NMDAR2A (rat) SSPRDKIytIDGEKE Y1118-p
T1119-p
SPRDKIytIDGEKEP
0 3
NMDAR2A (human) SPRDKIyTIDGEKEP T1119
NMDAR2A (mouse) SPRDKIYTIDGEKEP T1119
NMDAR2A (rat) SPRDKIytIDGEKEP T1119-p
S1127-p
IDGEKEPsFHLDPPQ
0 4
NMDAR2A (human) IDGEKEPGFHLDPPQ G1127
NMDAR2A (mouse) IDGEKEPSFHLDPPQ S1127
NMDAR2A (rat) IDGEKEPsFHLDPPQ S1127-p
S1163
ENFRKGDSTLPMNRN
0 1
NMDAR2A (human) ENFRKGDstLPMNRN S1163-p
NMDAR2A (mouse) ENFRKGDSTLPMNRN S1163
NMDAR2A (rat) ENFRKGDSTLPMNRN S1163
T1164
NFRKGDSTLPMNRNP
0 1
NMDAR2A (human) NFRKGDstLPMNRNP T1164-p
NMDAR2A (mouse) NFRKGDSTLPMNRNP T1164
NMDAR2A (rat) NFRKGDSTLPMNRNP T1164
P1179
LHNEDGLPNNDQyKL
0 1
NMDAR2A (human) LHNEEGLsNNDQyKL S1179-p
NMDAR2A (mouse) LHNEDGLPNNDQYKL P1179
NMDAR2A (rat) LHNEDGLPNNDQyKL P1179
Y1184-p
GLPNNDQyKLyAKHF
Upstream
2 21
Treatment
  • ischemia/reperfusion
NMDAR2A (human) GLsNNDQyKLySKHF Y1184-p
NMDAR2A (mouse) GLPNNDQYKLyAKHF Y1184
NMDAR2A (rat) GLPNNDQyKLyAKHF Y1184-p
Y1187-p
NNDQyKLyAKHFTLK
Upstream
2 44
Treatment
  • ischemia/reperfusion
NMDAR2A (human) NNDQyKLySKHFTLK Y1187-p
NMDAR2A (mouse) NNDQYKLyAKHFTLK Y1187-p
NMDAR2A (rat) NNDQyKLyAKHFTLK Y1187-p
S1198-p
FTLKDKGsPHSEGSD
0 3
NMDAR2A (human) FTLKDKGSPHSETSE S1198
NMDAR2A (mouse) FTLKDKGsPHsEGsD S1198-p
NMDAR2A (rat) FTLKDKGsPHSEGSD S1198-p
S1201
KDKGsPHSEGSDRYR
0 1
NMDAR2A (human) KDKGSPHSETSERYR S1201
NMDAR2A (mouse) KDKGsPHsEGsDRYR S1201-p
NMDAR2A (rat) KDKGsPHSEGSDRYR S1201
S1204
GsPHSEGSDRYRQNS
0 1
NMDAR2A (human) GSPHSETSERYRQNS S1204
NMDAR2A (mouse) GsPHsEGsDRYRQNS S1204-p
NMDAR2A (rat) GsPHSEGSDRYRQNS S1204
T1223-p
SCLSNLPtysGHFtM
1 8
NMDAR2A (human) SCLSNMPTYSGHFTM T1223
NMDAR2A (mouse) SCLSNLPtYSGHFTM T1223-p
NMDAR2A (rat) SCLSNLPtysGHFtM T1223-p
Y1224-p
CLSNLPtysGHFtMR
Upstream
1 34
Treatment
  • ischemia/reperfusion
NMDAR2A (human) CLSNMPTYSGHFTMR Y1224
NMDAR2A (mouse) CLSNLPtYSGHFTMR Y1224
NMDAR2A (rat) CLSNLPtysGHFtMR Y1224-p
S1225-p
LSNLPtysGHFtMRs
1 2
NMDAR2A (human) LSNMPTYSGHFTMRS S1225
NMDAR2A (mouse) LSNLPtYSGHFTMRs S1225
NMDAR2A (rat) LSNLPtysGHFtMRs S1225-p
T1229-p
PtysGHFtMRsPFkC
1 2
NMDAR2A (human) PTYSGHFTMRSPFKC T1229
NMDAR2A (mouse) PtYSGHFTMRsPFKC T1229
NMDAR2A (rat) PtysGHFtMRsPFkC T1229-p
S1232-p
sGHFtMRsPFkCDAC
Upstream
Downstream
6 8
Effects on Modified Protein
  • activity, induced
  • intracellular localization
Effects on Biological Processes:
  • neural plasticity
Kinase, in vitro:
  • CDK5 (rat)
Putative in vivo kinases:
  • CDK5 (rat)
Treatment
  • glutamic acid
  • ischemia
  • ischemia/reperfusion
  • painful stimulus
  • seliciclib
view more >
NMDAR2A (human) SGHFTMRSPFKCDAC S1232
NMDAR2A (mouse) SGHFTMRsPFKCDAC S1232-p
NMDAR2A (rat) sGHFtMRsPFkCDAC S1232-p
K1235-ub
FtMRsPFkCDACLRM
0 1
NMDAR2A (human) FTMRSPFKCDACLRM K1235
NMDAR2A (mouse) FTMRsPFKCDACLRM K1235
NMDAR2A (rat) FtMRsPFkCDACLRM K1235-ub
Y1246-p
CLRMGNLyDIDEDQM
Upstream
3 31
NMDAR2A (human)
Y1246-p
NMDAR2A (mouse)
Y1246-p
NMDAR2A (rat)
Y1246-p
Treatment
  • 1-methoxyoctadecan-1-ol
  • glutamic acid
NMDAR2A (human) CLRMGNLyDIDEDQM Y1246-p
NMDAR2A (mouse) CLRMGNLyDIDEDQM Y1246-p
NMDAR2A (rat) CLRMGNLyDIDEDQM Y1246-p
T1262-p
QETGNPAtREEVyQQ
0 1
NMDAR2A (human) QETGNPATGEQVyQQ T1262
NMDAR2A (mouse) QETGNPATREEAYQQ T1262
NMDAR2A (rat) QETGNPAtREEVyQQ T1262-p
Y1267-p
PAtREEVyQQDWSQN
4 26
NMDAR2A (human) PATGEQVyQQDWAQN Y1267-p
NMDAR2A (mouse) PATREEAYQQDWSQN Y1267
NMDAR2A (rat) PAtREEVyQQDWSQN Y1267-p
S1291-p
LRINRQHsyDNILDK
5 14
NMDAR2A (human) LRISRQHsyDNIVDK S1291-p
NMDAR2A (mouse) LKINRQHsyDNILDK S1291-p
NMDAR2A (rat) LRINRQHsyDNILDK S1291-p
Y1292-p
RINRQHsyDNILDKP
3 17
NMDAR2A (human) RISRQHsyDNIVDKP Y1292-p
NMDAR2A (mouse) KINRQHsyDNILDKP Y1292-p
NMDAR2A (rat) RINRQHsyDNILDKP Y1292-p
S1312-p
SRPSRSIsLKDRERL
2 0
NMDAR2A (human) SRPSRSISLKDRERL S1312
NMDAR2A (mouse) SRPSRSIsLKDRERL S1312-p
NMDAR2A (rat) SRPSRSIsLKDRERL S1312-p
Y1325-p
RLLEGNLyGsLFSVP
8 86
NMDAR2A (human) RLLEGNFyGSLFSVP Y1325-p
NMDAR2A (mouse) RLLEGNLyGsLFSVP Y1325-p
NMDAR2A (rat) RLLEGNLyGsLFSVP Y1325-p
S1327-p
LEGNLyGsLFSVPSS
1 4
NMDAR2A (human) LEGNFyGSLFSVPSS S1327
NMDAR2A (mouse) LEGNLyGsLFSVPss S1327-p
NMDAR2A (rat) LEGNLyGsLFSVPSS S1327-p
S1333
GsLFSVPSSKLLGNK
0 1
NMDAR2A (human) GSLFSVPSSKLSGKK S1333
NMDAR2A (mouse) GsLFSVPssKLLGNk S1333-p
NMDAR2A (rat) GsLFSVPSSKLLGNK S1333
S1334
sLFSVPSSKLLGNKS
0 1
NMDAR2A (human) SLFSVPSSKLSGKKS S1334
NMDAR2A (mouse) sLFSVPssKLLGNkS S1334-p
NMDAR2A (rat) sLFSVPSSKLLGNKS S1334
K1340
SSKLLGNKSSLFPQG
0 1
NMDAR2A (human) SSKLSGKKSSLFPQG K1340
NMDAR2A (mouse) ssKLLGNkSSLFPQG K1340-ub
NMDAR2A (rat) SSKLLGNKSSLFPQG K1340
K1352
PQGLEDSKRSKSLLP
0 1
NMDAR2A (human) PQGLEDSKRSKSLLP K1352
NMDAR2A (mouse) PQGLEDSkRSKSLLP K1352-ub
NMDAR2A (rat) PQGLEDSKRSKSLLP K1352
T1370-p
SDNPFLHtyGDDQRL
1 2
NMDAR2A (human) SDNPFLHSHRDDQRL S1370
NMDAR2A (mouse) SDNPFLHTYGDDQRL T1370
NMDAR2A (rat) SDNPFLHtyGDDQRL T1370-p
Y1371-p
DNPFLHtyGDDQRLV
1 6
NMDAR2A (human) DNPFLHSHRDDQRLV H1371
NMDAR2A (mouse) DNPFLHTYGDDQRLV Y1371
NMDAR2A (rat) DNPFLHtyGDDQRLV Y1371-p
S1384-p
LVIGRCPsDPyKHsL
1 9
NMDAR2A (human) LVIGRCPSDPyKHSL S1384
NMDAR2A (mouse) LVIGRCPSDPyKHSL S1384
NMDAR2A (rat) LVIGRCPsDPyKHsL S1384-p
Y1387-p
GRCPsDPyKHsLPSQ
Upstream
5 14
Treatment
  • status epilepticus
NMDAR2A (human) GRCPSDPyKHSLPSQ Y1387-p
NMDAR2A (mouse) GRCPSDPyKHSLPSQ Y1387-p
NMDAR2A (rat) GRCPsDPyKHsLPSQ Y1387-p
S1390-p
PsDPyKHsLPSQAVN
0 2
NMDAR2A (human) PSDPyKHSLPSQAVN S1390
NMDAR2A (mouse) PSDPyKHSLPSQAVN S1390
NMDAR2A (rat) PsDPyKHsLPSQAVN S1390-p
S1399-p
PSQAVNDsyLRSSLR
0 1
NMDAR2A (human) PSQAVNDSYLRSSLR S1399
NMDAR2A (mouse) PSQAVNDSYLRSSLR S1399
NMDAR2A (rat) PSQAVNDsyLRSSLR S1399-p
Y1400-p
SQAVNDsyLRSSLRS
1 8
NMDAR2A (human) SQAVNDSYLRSSLRS Y1400
NMDAR2A (mouse) SQAVNDSYLRSSLRS Y1400
NMDAR2A (rat) SQAVNDsyLRSSLRS Y1400-p
S1416-p
ASYCSRDsRGHSDVy
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • PKCA (rat)
NMDAR2A (human) ASYCSRDSRGHNDVy S1416
NMDAR2A (mouse) ASYCSRDSRGHsDVy S1416
NMDAR2A (rat) ASYCSRDsRGHSDVy S1416-p
S1420
SRDsRGHSDVyIsEH
0 1
NMDAR2A (human) SRDSRGHNDVyISEH N1420
NMDAR2A (mouse) SRDSRGHsDVyISEH S1420-p
NMDAR2A (rat) SRDsRGHSDVyIsEH S1420
Y1423-p
sRGHSDVyIsEHVMP
2 14
NMDAR2A (human) SRGHNDVyISEHVMP Y1423-p
NMDAR2A (mouse) SRGHsDVyISEHVMP Y1423-p
NMDAR2A (rat) sRGHSDVyIsEHVMP Y1423-p
S1425-p
GHSDVyIsEHVMPyA
1 1
NMDAR2A (human) GHNDVyISEHVMPYA S1425
NMDAR2A (mouse) GHsDVyISEHVMPYA S1425
NMDAR2A (rat) GHSDVyIsEHVMPyA S1425-p
Y1431-p
IsEHVMPyAANKNtM
1 13
NMDAR2A (human) ISEHVMPYAANKNNM Y1431
NMDAR2A (mouse) ISEHVMPYAANKNNM Y1431
NMDAR2A (rat) IsEHVMPyAANKNtM Y1431-p
T1437-p
PyAANKNtMysTPRV
0 1
NMDAR2A (human) PYAANKNNMYSTPRV N1437
NMDAR2A (mouse) PYAANKNNMYSTPRV N1437
NMDAR2A (rat) PyAANKNtMysTPRV T1437-p
Y1439-p
AANKNtMysTPRVLN
1 10
NMDAR2A (human) AANKNNMYSTPRVLN Y1439
NMDAR2A (mouse) AANKNNMYSTPRVLN Y1439
NMDAR2A (rat) AANKNtMysTPRVLN Y1439-p
S1440-p
ANKNtMysTPRVLNS
1 1
NMDAR2A (human) ANKNNMYSTPRVLNS S1440
NMDAR2A (mouse) ANKNNMYSTPRVLNS S1440
NMDAR2A (rat) ANKNtMysTPRVLNS S1440-p
S1449
PRVLNSCSNRRVYKK
0 1
NMDAR2A (human) PRVLNSCSNRRVYKK S1449
NMDAR2A (mouse) PRVLNSCsNRRVYKK S1449-p
NMDAR2A (rat) PRVLNSCSNRRVYKK S1449
S1459-p
RVYKKMPsIEsDV__
2 10
NMDAR2A (human) RVYKKMPsIESDV__ S1459-p
NMDAR2A (mouse) RVYKKMPsIEsDV__ S1459-p
NMDAR2A (rat) RVYKKMPsIEsDV__ S1459-p
S1462-p
KKMPsIEsDV_____
1 2
NMDAR2A (human) KKMPsIESDV_____ S1462
NMDAR2A (mouse) KKMPsIEsDV_____ S1462-p
NMDAR2A (rat) KKMPsIEsDV_____ S1462-p
Y251
RSLGLTGYDFFWIVP
0 1
NMDAR2A (human) RSLGLTGyDFFWIVP Y251-p
NMDAR2A (mouse) RSLGLTGYDFFWIVP Y251
NMDAR2A (rat) RSLGLTGYDFFWIVP Y251
S262
WIVPSLVSGNTELIP
0 1
NMDAR2A (human) WIVPSLVsGNTELIP S262-p
NMDAR2A (mouse) WIVPSLVSGNTELIP S262
NMDAR2A (rat) WIVPSLVSGNTELIP S262